METABOLIC-01 · Protocol
Member - $149/mo, medication included when prescribed
Requires an online consultation with a licensed provider.
Important safety information
A metabolic protocol that keeps the less glamorous parts in view: contraindication screening, nutrition, activity, side effects, and a plan beyond the first refill.
Signs + Readout
A weight trend that no longer responds to the old playbook can be worth a clinical conversation. It still does not make a GLP-1 medicine the automatic answer.
Large trials show meaningful average weight change for FDA-approved GLP-1 products. Individual results vary, and compounded versions are not FDA approved or verified by the FDA for safety or effectiveness.
Semaglutide 2.4 mg in the 2021 STEP 1 trial. A trial average for an FDA-approved regimen, not a promised result for a compounded product.
What's included
Weight history, metabolic context, current medications, contraindication screening, goals, and state routing.
Provider consultation · $20-35 pass-through. A licensed provider decides whether a GLP-1 medicine fits and which listed option is appropriate.
Medication included when prescribed in the Member · $149/mo tier for products represented in this catalog.
Labs · about $280 at cost. The provider selects relevant metabolic and safety markers.
Side effects, nutrition, activity, lean-mass risk, and any medication changes stay in the provider conversation.
How it works
Proof and legitimacy
A licensed provider owns the prescribing decision. A catalog selection does not bypass contraindication screening.
The page distinguishes the listed compounded products from FDA-approved branded products and keeps the disclaimer attached.
Member · $149/mo, Labs · about $280 at cost, and Provider consultation · $20-35 pass-through. The receipt uses the data layer, not additive marketing math.
Compounded semaglutide and tirzepatide are live. Oral drops stay marked soon, with no date promised.
Important safety information
The FDA-approved semaglutide and tirzepatide labels are the clearest safety references for their active ingredients. Compounded products are not FDA approved and may differ from the approved products.
Sources: FDA Wegovy prescribing information; FDA Zepbound prescribing information; FDA concerns with unapproved GLP-1 drugs; STEP 1 trial. Final clinical guidance comes from the current dispensed-product label, pharmacy, and provider.
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
First month receipt
Medication included when prescribed.
Requires an online consultation with a licensed provider. Important safety information
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
A monthly vial considered by a licensed provider when appropriate.
Requires an online consultation with a licensed provider.
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
A planned oral form. Availability is not promised.
Requires an online consultation with a licensed provider.
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
A planned tablet listing, separated from live protocols.
Requires an online consultation with a licensed provider.
Read before deciding
GLP-1 FAQ
Informational, not medical advice. A licensed provider in your state makes the call once they have seen your labs.
Both are live catalog options, but the page does not choose for you. The provider reviews medical history, contraindications, prior response, goals, and availability before deciding whether either fits.
The products shown here are compounded and are not FDA approved. FDA-approved branded semaglutide and tirzepatide products have their own labels. The provider decides what is clinically appropriate and available for the individual patient.
Regain can occur after discontinuation, especially when the surrounding plan has not changed. Intake should include the longer-term plan, not only how medication starts.
Weight loss can include lean mass. Nutrition, resistance training, rate of loss, and the individual clinical picture belong in the provider conversation. This page does not prescribe a protein or training target.
The oral drops are marked soon and no availability or equivalence claim is made. If offered, the provider would review the evidence and route-specific context.
Labs · about $280 at cost, Provider consultation · $20-35 pass-through, and Member · $149/mo. The estimated subtotal appears in the receipt before intake.
Your next useful step
Share your metabolic history, goals, medications, and existing labs. A licensed provider decides whether a GLP-1 medicine belongs in the conversation. Read the peptides wiki first if you want the mechanism.
Start GLP-1 intakeRequires an online consultation with a licensed provider. Important safety information